1. Postmortem analysis of invasive aspergillosis in a tertiary care hospital

   • M. Vogeser
   • A. Haas
   • G. Ruckdeschel

   Articles Pages: 1 - 6

2. Comparison of polymerase chain reaction with light microscopy for detection of microsporidia in clinical specimens

   • S. Katzwinkel-Wladarsch
   • P. Deplazes
   • H. Rinder

   Articles Pages: 7 - 10

3. Antimicrobial susceptibility ofStreptococcus pneumoniae isolated from pediatric carriers in Spain

   • J. García-de-Lomas
   • C. Gimeno
   • B. Garijo

   Notes Pages: 11 - 13

4. Synergistic effect of azithromycin on the phagocytic killing ofStaphylococcus aureus by human polymorphonuclear leukocytes

   • I. Herrera-Insúa
   • P. Pérez
   • J. Prieto

   Notes Pages: 13 - 16

5. Clearances ofCandida albicans-derived α- and β-linked mannose residues in sera from patients with candidiasis

   • D. Poulain
   • R. Robert
   • D. Camus

   Notes Pages: 16 - 20

6. Serotyping and susceptibility to macrolides and other antimicrobial drugs ofStreptococcus pyogenes isolated from patients with invasive diseases in Southern Israel

   • I. Weiss
   • Z. Gorodnitzky
   • P. Yagupsky

   Notes Pages: 20 - 23

7. Detection ofAspergillus DNA in bronchoalveolar lavage fluid of AIDS patients by the polymerase chain reaction

   • E. Bart-Delabesse
   • A. Marmorat-Khuong
   • S. Bretagne

   Letters Pages: 24 - 25

8. Oral terbinafine for treatment of pulmonaryPseudallescheria boydii infection refractory to itraconazole therapy

   • P. E. Verweij
   • N. J. M. Cox
   • J. F. G. Meis

   Letters Pages: 26 - 28

9. Introduction

   • F. Meunier

   EditorialNotes Pages: 31 - 31

10. Practical modalities for prevention of fungal infections in cancer patients

    • B. E. De Pauw

    OriginalPaper Pages: 32 - 41

11. Key issues concerning fungistatic versus fungicidal drugs

    • J. R. Graybill
    • D. S. Burgess
    • T. C. Hardin

    OriginalPaper Pages: 42 - 50

12. Trends in immunotherapy of fungal infections

    • B. J. Kullberg

    OriginalPaper Pages: 51 - 55

13. Hematopoietic growth factors in cancer patients with invasive fungal infections

    • F. Offner

    OriginalPaper Pages: 56 - 63

14. Biopharmaceutical aspects of lipid formulations of amphotericin B

    • G. Storm
    • E. van Etten

    OriginalPaper Pages: 64 - 73

15. Safety of amphotericin B colloidal dispersion

    • R. Herbrecht

    OriginalPaper Pages: 74 - 80

16. Diversity of lipid-based polyene formulations and their behavior in biological systems

    • K. M. Wasan
    • G. Lopez-Berestein

    OriginalPaper Pages: 81 - 92

17. Pradimicins: A novel class of broad-spectrum antifungal compounds

    • T. J. Walsh
    • N. Giri

    OriginalPaper Pages: 93 - 97

18. Economic aspects of treatment for fungal infections in cancer patients

    • K. Torfs

    OriginalPaper Pages: 98 - 107

19. Announcements

    Announcement Pages: 108 - 109